Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Some want in before Q1 financials for an update

<< Previous

Bullboard Posts

Next >>

Comment by skier59on May 27, 2022 2:30pm

122 Views

Post# 34712928

RE:RE:RE:RE:RE:RE:Some want in before Q1 financials for an update

This is the most important data for me right now.
Enjoy your weekend.

ScienceFirst wrote: It's a FOMO trading. It would be interesting to have a real one based on clear and undisputable data.

Again, I don't expect many new treated patients since April 29. But that would be interesting if, in that last month, many have moved categories and that these %CR and %DR start to increase and convert.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant